MedPath

Rivanex 15

Brand Name: Rivanex 15

Generic Name: Rivaroxaban

Active
Registration Number

DRP-15420

Dosage Form

Film Coated Tablet

Issuance Date

August 1, 2024

Expiry Date

August 1, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength15 mg
PackagingAlu/PVC blister pack x 10's (Box of 30's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Antithrombotic Agent (Direct Factor Xa Inhibitor)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

RivaroxabanActive
Monograph: Rivaroxaban

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform